Ceretas Limited (CTS) is engaged in research and development of a novel therapeutic ultrasound technology licensed from UniQuest for the purpose of commercialising a portable, image-guided therapeutic ultrasound platform designed for the treatment of neurodegenerative disease, particularly Alzheimer's disease.
Find out what a historical investment in Ceretas would be worth today using our CTS stock calculator.
Buying CTS shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Ceretas in minutes.
Sign up with some I.D. and zero paperwork
Add funds to your account
Make your first investment in CTS
What is the ticker symbol of Ceretas?
The ticker symbol for Ceretas is CTS.
How much is one share of CTS?
One share of CTS is valued at $0.91 as of 20 November 2026.
What is the market capitalisation of Ceretas CTS?
As of 20 November 2026 Ceretas has a market cap of $44.06M.
What is the 52-week high for Ceretas stock?
The Ceretas 52-week high stock price is $1.11.
What is the 52-week low for Ceretas stock?
The Ceretas 52-week low stock price is $0.43.
Can I buy CTS shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy CTS shares and over 13,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.